U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT07526987) titled 'Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis' on April 08.

Brief Summary: The aim of this study is to assess the efficacy and safety of minocycline in improving functional outcome among patients with acute ischaemic stroke receiving intravenous thrombolysis.

Study Start Date: May 01

Study Type: INTERVENTIONAL

Condition: Ischaemic Stroke

Intervention: DRUG: Minocycline Hydrochloride Capsule (50 mg per capsule)

A loading dose of 200 mg will be administered before intravenous thrombolysis or within 2 hours after the initiation of intravenous thrombolysis, followed...